George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
More important EME have just retweeted this with the comment Thank you for the mention. Now given where the drill should be at the moment would they make such a comment if they did not have some optimism at the outcome? Interesting
How’s the short going Luckcounts. You are out of luck mate
I think we are onto 2 winners in AVCT and EME Timster. As I have been in EME since 2006?I certainly hope so!!
To suggest the SP will stay around the 70p level until mid summer news may fit in with your trader narrative but flys in the face of reality. Even in the unlikely event that there is no other news until then, the sheer potential of positive AVA6K news then will be reflected in a rising SP in the meantime
Pleased and encouraged by the progress in AVA6K
Nothing much for the trolls in this update who are consequently relatively quiet this morning. Should now form a solid base for SP appreciation with lift off mid summer with the AVA6K results
The main takeaway is that AVA6K is on track
We know it is priced in but the history of this share tells us that MM/trolls/ traders etc will take advantage of this to initially drop the price. I agree it will be intra day only and quickly recover
It could be a tale of 2 halves tomorrow. Confirmation that we are no longer developing the Covid LFD with he rider that the work developing that has assisted with the roll out of future LFD targeting other diseases like sepsis. The other half could be all going to plan with AVA6K with all the benefits accruing from that. MM to drop the price hard initially in the light of the LFD news with investors buoyed by the AVA6K news using the new ISA funds to buy the shares off them. Not long to wait now
Could you post a link to the Avacta telegram group please
Who cares now about the LFD. Why after over 7 months into the AVA6K trials would they be presenting at such a high profile event in the US unless that trial was meeting expectations. Yet another very big clue that all is going well
Looking at the potential diagnostic uses for Affidx detailed in the Presentation makes Al’s decision to withdraw the Covid test to get it right appear logical despite the short term loss of revenue. Avct are looking ahead way beyond covid in building a reputation for highly accurate LFD testing across a range of diseases. For the LTH the affimer based LFD is likely to create many potential revenue streams in the future that could potentially been put at risk if the original covid test with its imperfections had not been withdrawn. There would also be the added bonus of lowering costs in a self testing market that is still in its infancy
Agree that Medusa will still see value and there is no way 40 staff in Wetherby will be twiddling their thumbs when there is so much potential in affimer based antigen tests across a range of other diseases
Investing on the stock market is a calculated risk.
- why should Al look cheerful when he is commenting on cancer trials with the terminally ill?
- LFT not dead in he water but timing dependent on regulatory authorities view of the new revised tests. In the meantime more knowledge gained to assist with future tests
- Funding fine for at least the next 12 months with multiple funding opportunities prior to that not least from a successful Phase 1a outcome mid year
- very pleased with AVA6K progress to date with a major inflection point coming mid year.
- clear and concise overview of where the company stands today with results to follow end of Q1
Like many sitting on a large paper loss but unlike some can see the bigger picture and not whingeing about it!
The SP action today vindicates Al’s decision to do the Roadshows this week. The sooner we get more institutions holding than ten bob traders the sooner we will reduce the volatility and realise the long term value in this company
Great news. The clues were there. Patience rewarded
Al cannot say anything price sensitive at these roadshows which haven’t previously been announced to the market so I would anticipate a 7.00am RNS Monday or Tuesday through a trading update. It is highly unlikely he would go to all this PR trouble if he was simply repeating info that is already publicly available and if he didn’t have something positive to say. I would anticipate a AVA6K update and the clues are already out there to indicate that we are nearing a pivotal period in Avacta’s short history. Reasons to be both optimistic and nervous.
Update on AVA6K in the next fortnight anyone? Can’t see Al doing a Roadshow over 3 days beginning February 1st without one. Great buying opp for anyone with spare cash available